• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有非典型或间变性特征的星形细胞瘤患者的生存情况和预后

Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.

作者信息

Nelson D F, Nelson J S, Davis D R, Chang C H, Griffin T W, Pajak T F

出版信息

J Neurooncol. 1985;3(2):99-103. doi: 10.1007/BF02228884.

DOI:10.1007/BF02228884
PMID:4031977
Abstract

This study confirms the importance of histologic tumor necrosis as a major prognostic variable in malignant glioma. Necrosis is present in glioblastoma multiforme (GBM), and absent in astrocytoma with atypical or anaplastic features (AAF). This paper evaluates 94 patients with AAF and 462 patients with GBM treated with radiation therapy with or without BCNU on 3 consecutive randomized protocols of the Radiation Therapy Oncology Group (RTOG) between 1974 and 1983. Multivariate analyses of the 556 patients confirmed histology as a significant independent variable that is prognostically relatively more important than Karnofsky performance status (KPS) and extent of surgery, and somewhat less important than age. The median survival for AAF was 36.2 months and for GBM was 8.6 months. In addition, separate multivariate analyses of AAf cases determined that the extent of surgery is a significant independent variable that is relatively more important than KPS, but less important than age. The median survival of AAF patients who underwent surgical excision was 46.8 months compared with 15.2 months for those biopsied (p less than .001).

摘要

本研究证实了组织学肿瘤坏死作为恶性胶质瘤主要预后变量的重要性。坏死存在于多形性胶质母细胞瘤(GBM)中,而在具有非典型或间变性特征(AAF)的星形细胞瘤中不存在。本文评估了1974年至1983年间在放射治疗肿瘤学组(RTOG)的3个连续随机方案中接受放疗(有或无卡氮芥)治疗的94例AAF患者和462例GBM患者。对这556例患者的多变量分析证实,组织学是一个显著的独立变量,在预后方面相对比卡氏功能状态(KPS)和手术范围更重要,且比年龄稍次要。AAF的中位生存期为36.2个月,GBM为8.6个月。此外,对AAF病例的单独多变量分析确定,手术范围是一个显著的独立变量,相对比KPS更重要,但比年龄次要。接受手术切除的AAF患者的中位生存期为46.8个月,而接受活检的患者为15.2个月(p小于0.001)。

相似文献

1
Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.具有非典型或间变性特征的星形细胞瘤患者的生存情况和预后
J Neurooncol. 1985;3(2):99-103. doi: 10.1007/BF02228884.
2
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.丙卡巴肼、洛莫司汀和长春新碱(PCV)化疗用于间变性星形细胞瘤:对放射肿瘤学组方案的回顾性研究,比较卡莫司汀或PCV辅助化疗的生存率。
J Clin Oncol. 1999 Nov;17(11):3389-95. doi: 10.1200/JCO.1999.17.11.3389.
3
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.溴脱氧尿苷放射增敏对恶性胶质瘤患者生存的影响:对来自北加利福尼亚肿瘤学组(NCOG)和放射治疗肿瘤学组(RTOG)针对多形性胶质母细胞瘤和间变性星形细胞瘤的试验生存数据的回顾性比较。
Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):653-9. doi: 10.1016/s0360-3016(97)00770-0.
4
Central pathology review in clinical trials for patients with malignant glioma. A Report of Radiation Therapy Oncology Group 83-02.恶性胶质瘤患者临床试验中的中心病理学评估。放射治疗肿瘤学组83 - 02报告。
Cancer. 1995 Jul 15;76(2):307-13. doi: 10.1002/1097-0142(19950715)76:2<307::aid-cncr2820760222>3.0.co;2-l.
5
Radiation Therapy Oncology Group (RTOG) survival data on anaplastic astrocytomas of the brain: does a more aggressive form of treatment adversely impact survival?放射治疗肿瘤学组(RTOG)关于脑间变性星形细胞瘤的生存数据:更积极的治疗形式是否会对生存产生不利影响?
Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1351-6. doi: 10.1016/0360-3016(89)90549-x.
6
Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.
J Neurooncol. 1992 Mar;12(3):219-27. doi: 10.1007/BF00172709.
7
Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.超分割放射治疗与双氯乙基亚硝脲治疗恶性胶质瘤——在1.2 Gy每日两次分割剂量达72.0 Gy时观察到的可能优势:放射治疗肿瘤学组8302方案报告
Int J Radiat Oncol Biol Phys. 1993 Jan 15;25(2):193-207. doi: 10.1016/0360-3016(93)90340-2.
8
Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.采用分次腔内放射免疫疗法治疗的世界卫生组织III级和IV级神经胶质瘤患者的长期预后。
J Neurosurg. 2015 Sep;123(3):760-70. doi: 10.3171/2014.12.JNS142168. Epub 2015 Jul 3.
9
Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.术后放疗与术后放疗联合化疗在恶性胶质瘤多学科管理中的比较。放射治疗肿瘤学组与东部肿瘤协作组联合研究。
Cancer. 1983 Sep 15;52(6):997-1007. doi: 10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2.
10
Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.少突胶质细胞成分对间变性星形细胞瘤患者生存的影响:放射治疗肿瘤学组83-02报告
Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):911-4. doi: 10.1016/s0360-3016(97)00126-0.

引用本文的文献

1
Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma.载顺铂聚氰基丙烯酸丁酯纳米粒对胶质母细胞瘤的疗效
Tumour Biol. 2014 May;35(5):4799-806. doi: 10.1007/s13277-014-1630-9. Epub 2014 Jan 19.
2
Brachytherapy for brain tumors.脑肿瘤的近距离放射治疗。
J Neurooncol. 2005 May;73(1):71-86. doi: 10.1007/s11060-004-2352-4.
3
A comparative survival evaluation and assessment of interclassification concordance in adult supratentorial astrocytic tumors.

本文引用的文献

1
Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.术后放疗与术后放疗联合化疗在恶性胶质瘤多学科管理中的比较。放射治疗肿瘤学组与东部肿瘤协作组联合研究。
Cancer. 1983 Sep 15;52(6):997-1007. doi: 10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2.
2
Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas.坏死作为幕上恶性星形细胞瘤的预后标准。
Cancer. 1983 Aug 1;52(3):550-4. doi: 10.1002/1097-0142(19830801)52:3<550::aid-cncr2820520327>3.0.co;2-c.
3
Pathol Oncol Res. 2000;6(1):46-52. doi: 10.1007/BF03032658.
4
Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy.采用化疗与放疗相结合的积极方案治疗间变性胶质瘤的优势。
J Neurooncol. 1997 Sep;34(2):179-85. doi: 10.1023/a:1005705624858.
5
Proliferative activity and prognosis of low-grade astrocytomas.
J Neurooncol. 1997 Aug;34(1):31-5. doi: 10.1023/a:1005755119526.
6
Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas.用阿糖胞苷(ACNU)进行动脉内化疗及对无法手术的恶性胶质瘤进行放射治疗。
J Neurooncol. 1996 Feb;27(2):141-7. doi: 10.1007/BF00177477.
7
A grading study of gliomas using computer aided malignancy classification and histologic morphometry.
J Neurooncol. 1996 Jan;27(1):75-85. doi: 10.1007/BF00146087.
8
Management of primary malignant brain tumours.原发性恶性脑肿瘤的管理
J Neurol Neurosurg Psychiatry. 1996 Jan;60(1):2-5. doi: 10.1136/jnnp.60.1.2.
9
Interstitial brachytherapy and hyperthermia for malignant gliomas.间质性近距离放射疗法和热疗治疗恶性胶质瘤。
J Neurooncol. 1993 Aug;17(2):161-6. doi: 10.1007/BF01050219.
10
The basis for current treatment recommendations for malignant gliomas.恶性胶质瘤当前治疗建议的依据。
J Neurooncol. 1994;20(2):111-20. doi: 10.1007/BF01052722.
Evaluation of survival data and two new rank order statistics arising in its consideration.
生存数据的评估以及在考虑过程中出现的两个新的排序统计量。
Cancer Chemother Rep. 1966 Mar;50(3):163-70.